• Special Event

CPHI Milan 2026: Networking Reception

Wednesday Oct 7, 2026
Park Hyatt Milano Milan, Italy Via Tommaso Grossi 1, 20121
Back to All Events

Event Details

Join Quotient Sciences for an Evening in Milan. 

After a busy day on the exhibition floor, we invite you to join us for an exclusive evening of networking, celebration, and conversation with industry peers and Quotient Sciences. Taking place in the heart of Milan, this relaxed and informal reception offers the perfect opportunity to connect while enjoying drinks and canapés.

We'll provide a short overview of our new AI-enhanced solution and the value it brings to drug development, this event is first and foremost a celebration. Expect a relaxed atmosphere focused on building relationships, sharing ideas and enjoying an evening with industry colleagues in one of Europe's most vibrant cities.  

What to Expect

  • An evening of celebration as we mark the launch of our new AI-driven service
  • Networking with industry peers, along with Quotient Sciences leadership and scientific teams
  • A brief introduction to our latest AI-enhanced formulation capabilities
  • An opportunity to discuss current and future development programmes in an informal setting

Why Attend?

The best conversations rarely happen on a busy exhibition stand. Join us for an evening designed to bring together customers, partners and industry innovators for meaningful discussions, new connections and a chance to celebrate what's next for pharmaceutical development. 

Spaces are limited and available by invitation only.

Learn more about the CPHI Milan 2026.

Meet our Experts

  • John McDermott - Quotient Sciences

    John McDermott

    VP, Scientific Consulting

  • Dr. Andrew Parker - Quotient Sciences

    Dr. Andrew Parker

    Executive Drug Development Consultant

  • Dr. Andrew Lewis

    Dr. Andrew Lewis

    Chief Scientific Officer

  • Matt Paterson

    Matt Paterson

    Chief Strategy Officer

Meet our experts:

We look forward to meeting you at the CPHI Milan 2026 Customer Drinks Reception this October.

John McDermott

VP, Scientific Consulting

John McDermott leads Quotient Sciences' global drug development consulting, research fellows, modeling & simulation, and clien...

About John
Dr. Andrew Parker

Executive Drug Development Consultant

Dr. Andrew Parker has over two decades of experience in the pharmaceutical industry, spanning from preclinical development, throug...

About Andrew
Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Matt Paterson

Chief Strategy Officer

Matt Paterson is Chief Strategy Officer at Quotient Sciences. With over 27 years of global experience in the pharmaceutical indust...

About Matt